BHC
Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC) has 19 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 20, 2026.
Insiders have net sold $133K over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Thomas J. Appio
- Employees:20,700
- HQ:Laval, QC, CA
- IPO:1994-03-29
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$133K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$2.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Lee Frank D.First filing | Director | Sale | 24,456 | $133K | May 20 | SEC ↗ |
Related companies
Bausch Health Companies Inc. is in the Healthcare sector.